Aigen Investment Management, LP Evolus, Inc. Transaction History

Aigen Investment Management, LP

  • $487 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$10.45 - $13.76 $47,401 - $62,415
4,536 Added 32.75%
18,388 $199,000
Q1 2024

May 14, 2024
SELL
$9.99 - $14.91 $373,316 - $557,171
-37,369 Reduced 72.96%
13,852 $193,000
Q4 2023

Feb 09, 2024
BUY
$7.6 - $10.53 $162,928 - $225,742
21,438 Added 71.98%
51,221 $539,000
Q3 2023

Nov 13, 2023
BUY
$7.15 - $10.2 $123,065 - $175,562
17,212 Added 136.92%
29,783 $272,000
Q2 2023

Aug 14, 2023
BUY
$7.23 - $10.52 $90,888 - $132,246
12,571 New
12,571 $91,000

Others Institutions Holding EOLS

# of Institutions
168
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $608M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Aigen Investment Management, LP Portfolio

Follow Aigen Investment Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Aigen Investment Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email